Daniel M. Hancock - 02 Sep 2021 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role: Director
Signature: /s/ Daniel Hancock
Issuer symbol: CYRX
Transactions as of: 02 Sep 2021
Net transactions value: -$30,325
Form type: 4
Filing time: 07 Sep 2021, 16:45:56 UTC
Previous filing: 30 Jun 2021
Next filing: 29 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYRX	Common Stock	Options Exercise	$8,237	+574	+12%	$14.35	5,201	02 Sep 2021	Direct	F1
transaction	CYRX	Common Stock	Sale	$38,562	-574	-11%	$67.18	4,627	02 Sep 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYRX	Option to purchase common stock	Options Exercise	$0	-574	-2.2%	$0.000000	25,000	02 Sep 2021	Common Stock	574	$14.35	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.
F2	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.41, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	1/12 of these options vested and became exercisable in equal monthly installments on the 2nd of each month for the twelve (12) months beginning on 05/02/2019.